Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 255738
Gene Symbol: PCSK9
PCSK9
0.010 AlteredExpression disease BEFREE In the present study, PCSK9 expression was measured in acute lymphoblastic leukemia (ALL) patients and was found to be significantly induced. 31812013 2020
Entrez Id: 3934
Gene Symbol: LCN2
LCN2
0.010 Biomarker disease BEFREE Serum neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for predicting high dose methotrexate associated acute kidney injury in children with acute lymphoblastic leukemia. 31676986 2020
Entrez Id: 5366
Gene Symbol: PMAIP1
PMAIP1
0.010 AlteredExpression disease BEFREE We investigated TP53 mutations in cell lines and 62 B-cell precursor acute lymphoblastic leukemia samples and evaluated the activity of APR-246 in TP53 mutated or wild type acute lymphoblastic leukemias. 31073076 2020
Entrez Id: 7295
Gene Symbol: TXN
TXN
0.010 Biomarker disease BEFREE Here, we show that the Trx inhibitor PX-12 reduced cell viability and induced cell death in a dose- and time-dependent manner in different ALL cell lines. 31352431 2020
Entrez Id: 57116
Gene Symbol: ZNF695
ZNF695
0.010 Biomarker disease BEFREE ALPK1, ACTN4, CALR, and ZNF695 were identified as the potential prognosis risk factors in adult ALL. 28485154 2019
Entrez Id: 3593
Gene Symbol: IL12B
IL12B
0.010 AlteredExpression disease BEFREE Moreover, gene expression analyses from children with ALL showed that patients with higher expression of either IL12A or IL12B exhibited prolonged survival. 31142509 2019
Entrez Id: 21
Gene Symbol: ABCA3
ABCA3
0.010 AlteredExpression disease BEFREE Inverse correlation was determined between the miR-335-3p and ABCA3 mRNA expression profiles in cALL patients (r = 0.5019, P = 0.002). 30639603 2019
Entrez Id: 84441
Gene Symbol: MAML2
MAML2
0.010 GeneticVariation disease BEFREE Inv(11)(q21q23); KMT2A-MAML2, a Recurrent Genetic Abnormality in T-Cell Therapy-related Acute Lymphoblastic Leukemia. 31343482 2019
Entrez Id: 8085
Gene Symbol: KMT2D
KMT2D
0.010 Biomarker disease BEFREE Cryptic ETV6-ABL1 Fusion and MLL2 Truncation Revealed by Integrative Clinical Sequencing in Multiply Relapsed Acute Lymphoblastic Leukemia. 30028819 2019
Entrez Id: 26269
Gene Symbol: FBXO8
FBXO8
0.010 Biomarker disease BEFREE <b>Abbreviations</b>: NK: natural killer cells; aNK: activated NK cells; EV: extracellular vesicles; ER: endoplasmic reticulum; ALL: acute lymphoblastic leukaemia; FBS: foetal bovine serum. 30891164 2019
Entrez Id: 7709
Gene Symbol: ZBTB17
ZBTB17
0.010 Biomarker disease BEFREE These observations suggest that targeting MIZ-1 could render current ALL chemotherapies more effective, with a better outcome for patients. 31273062 2019
Entrez Id: 8856
Gene Symbol: NR1I2
NR1I2
0.010 GeneticVariation disease BEFREE A few breakpoints detected in the SAR region were mapped within the AF9 region that was previously reported to translocate with the mixed lineage leukaemia (MLL) gene in an acute lymphoblastic leukaemia (ALL) patient. 30646906 2019
Entrez Id: 6345
Gene Symbol: SRL
SRL
0.010 GeneticVariation disease BEFREE A few breakpoints detected in the SAR region were mapped within the AF9 region that was previously reported to translocate with the mixed lineage leukaemia (MLL) gene in an acute lymphoblastic leukaemia (ALL) patient. 30646906 2019
Entrez Id: 100126315
Gene Symbol: MIR665
MIR665
0.010 AlteredExpression disease BEFREE Moreover, low EXT1 and high miR-665 expression levels in adult ALL bone marrow tissues are correlated with poor patient survival. 31465316 2019
Entrez Id: 29126
Gene Symbol: CD274
CD274
0.010 Biomarker disease BEFREE The higher expression of immune checkpoint molecules, in particular, CTLA-4 and PD-L1 are associated with a poorer prognosis in ALL, suggesting that selective use of the immune checkpoint blockade might improve the clinical outcomes in patients with ALL. 31570447 2019
Entrez Id: 4927
Gene Symbol: NUP88
NUP88
0.010 Biomarker disease BEFREE The nuclear pore proteins Nup88/214 and T-cell acute lymphatic leukemia-associated NUP214 fusion proteins regulate Notch signaling. 31186352 2019
Entrez Id: 1958
Gene Symbol: EGR1
EGR1
0.010 Biomarker disease BEFREE In order to determine whether the effect of HSP70 inhibition on apoptosis and proliferation of ALL cell lines could be achieved via regulation of Egr-1, we performed a loss-of-function experiment for Egr-1. 31521893 2019
Entrez Id: 81704
Gene Symbol: DOCK8
DOCK8
0.010 GeneticVariation disease BEFREE Compound Heterozygous DOCK8 Mutations in a Patient with B Lymphoblastic Leukemia and EBV-Associated Diffuse Large B Cell Lymphoma. 31267431 2019
Entrez Id: 811
Gene Symbol: CALR
CALR
0.010 Biomarker disease BEFREE In conclusion, our data suggest that, with proper systemic and intrathecal CNS prophylaxis, CRT could totally be omitted in CR1 without jeopardizing survival, while decreasing LAE in childhood ALL. 31837008 2019
Entrez Id: 64319
Gene Symbol: FBRS
FBRS
0.010 Biomarker disease BEFREE <b>Abbreviations</b>: NK: natural killer cells; aNK: activated NK cells; EV: extracellular vesicles; ER: endoplasmic reticulum; ALL: acute lymphoblastic leukaemia; FBS: foetal bovine serum. 30891164 2019
Entrez Id: 1271
Gene Symbol: CNTFR
CNTFR
0.010 Biomarker disease BEFREE The expressions of miR-146a and ciliary neurotrophic factor receptor (CNTFR) were detected by quantitative real-time polymerase chain reaction (qRT-PCR) in ALL and AML pediatric patients, as well as ALL (Jurkat) and AML (HL-60) cells. 31538427 2019
Entrez Id: 4179
Gene Symbol: CD46
CD46
0.010 GeneticVariation disease BEFREE A total of 96 children with ALL undergoing therapy with MCP-841 protocol were screened for all the ten exons of TPMT, exon 2, exon 3 and intron 2 of ITPA using bidirectional sequencing. 30806759 2019
Entrez Id: 3812
Gene Symbol: KIR3DL2
KIR3DL2
0.010 GeneticVariation disease BEFREE Whereas donor killer cell immunoglobulin-like receptor (KIR) genotype was shown to impact on relapse incidence in adult myeloid leukaemia similar studies in paediatric ALL are largely missing. 31089287 2019
Entrez Id: 6348
Gene Symbol: CCL3
CCL3
0.010 Biomarker disease BEFREE Here, we found that chemotherapeutic drugs (e.g., Ara-C, DNR, 6-MP) induced the expression of niche-protecting cytokines (GDF15, CCL3 and CCL4) in both ALL cell lines and primary cells in vitro. 30940905 2019
Entrez Id: 1116
Gene Symbol: CHI3L1
CHI3L1
0.010 Biomarker disease BEFREE This finding supports the idea of targeting YKL-40 as a new drug treatment of ALL and extends the use of resveratrol in antileukemia research. 30426549 2019